Kunder Chemicals Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
as on 01-01-2025
- Paid Up Capital ₹ 2.50 M
as on 01-01-2025
- Company Age 33 Year, 7 Months
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 1.69 Cr
as on 01-01-2025
- Revenue -59.55%
(FY 2023)
- Profit -161.51%
(FY 2023)
- Ebitda -106.19%
(FY 2023)
- Net Worth -14.07%
(FY 2023)
- Total Assets -19.15%
(FY 2023)
About Kunder Chemicals
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 2.50 M.
The company has closed loans amounting to ₹1.69 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Veenit Kunder and Nishant Kunder serve as directors at the Company.
- CIN/LLPIN
U24110MH1991PTC061895
- Company No.
061895
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
30 May 1991
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Kunder Chemicals?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Veenit Kunder  | Director | 10-Feb-2007 | Current |
| Nishant Kunder | Director | 01-Jan-2013 | Current |
Financial Performance of Kunder Chemicals.
Kunder Chemicals Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 59.55% decrease. The company also saw a substantial fall in profitability, with a 161.51% decrease in profit. The company's net worth observed a substantial decline by a decrease of 14.07%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Kunder Chemicals?
Unlock access to Kunder Chemicals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
The Hongkong & Shanghai Banking Corporation Limited Creation Date: 25 Aug 2015 | ₹1.50 Cr | Satisfied |
Syndicate Bank Creation Date: 12 Oct 2007 | ₹1.90 M | Satisfied |
How Many Employees Work at Kunder Chemicals?
Kunder Chemicals has a workforce of 46 employees as of Mar 22, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Kunder Chemicals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Kunder Chemicals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
